GLP-1 Telehealth Consultation: What to Expect (Step-by-Step Guide)

If you've been researching GLP-1 medications for weight loss — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound) — you've probably landed on the same question: what does a telehealth weight loss doctor consultation actually look like? Is it a 3-minute rubber stamp? A full intake process? Something in between?

This guide walks through the entire online semaglutide prescription process step by step — what happens before, during, and after your consultation, what providers are evaluating, who qualifies, and what to expect from a platform like Curapath.

What Is a GLP-1 Telehealth Consultation?

A GLP-1 telehealth consultation is a clinical evaluation conducted by a licensed provider — physician or nurse practitioner — through an asynchronous intake platform or live video visit. The provider reviews your health history, current medications, weight history, and relevant risk factors, then makes a prescribing decision: either a GLP-1 prescription (with a specific starting dose and titration schedule) or an explanation of why you're not currently a candidate.

It is a real medical consultation. The provider is licensed in your state, carries malpractice insurance, documents in an electronic health record, and is legally accountable for their prescribing decisions. A telehealth prescription carries the same legal weight as one written in a clinic — pharmacies cannot distinguish between the two, because there is no clinical distinction.

What telehealth eliminates is the overhead of in-person care: the exam room, the drive, the 45-minute wait, the billing staff. That's why a $49 telehealth consultation and a $300+ in-person visit deliver equivalent clinical outcomes for a straightforward GLP-1 case.

The Step-by-Step Process: How It Works at Curapath

Step 1: Complete Your Health Intake (10–15 Minutes)

The intake form is the clinical equivalent of a patient questionnaire you'd complete at an in-person office. It covers:

• Basic demographics: Name, date of birth, state of residence (determines which licensed providers can serve you)
• Weight history: Current weight, height, weight loss history, prior attempts
• Medical history: Current diagnoses (type 2 diabetes, hypertension, high cholesterol, sleep apnea, thyroid conditions)
• Medications: Current prescriptions — especially insulin, metformin, blood pressure medications, and anticoagulants
• Contraindication screening: Personal or family history of medullary thyroid carcinoma or MEN2, history of pancreatitis, pregnancy status
• GLP-1 history: Whether you've previously tried semaglutide or tirzepatide, and results
• Symptoms and goals: What you're hoping to achieve and your timeline

Be accurate and complete. The provider makes their decision based on what you submit — gaps or inaccuracies delay the process and can affect your prescription.

Step 2: Provider Review (Within 24 Hours)

A licensed provider reviews your intake and evaluates it against the clinical framework for GLP-1 prescribing: qualifying BMI (≥30, or ≥27 with a weight-related condition), contraindication absence, medication interaction check, and clinical appropriateness. This isn't an algorithm — it's a human provider reading your intake and making a judgment call.

For most straightforward cases, the review takes a few hours. You'll receive a notification when the provider has responded. No scheduling. No waiting room. No half-day blocked off your calendar.

Step 3: Prescription Decision

One of three outcomes:

1. Approved — prescription issued. The provider sends a prescription to your preferred pharmacy with your starting dose (typically 0.25mg/week semaglutide for the first 4 weeks) and a titration schedule. If you're filling at a compounding pharmacy, the provider will write accordingly.
2. Approved with follow-up needed. The provider may request labs (HbA1c, basic metabolic panel) before finalizing the prescription — particularly if you have diabetes, are on insulin, or have specific risk factors that warrant baseline bloodwork. This is less common but not rare.
3. Not a candidate at this time. If you don't meet qualifying criteria — BMI below threshold, active contraindication, medication interaction that can't be safely managed via telehealth — the provider explains why and, where appropriate, recommends next steps.

Step 4: Fill Your Prescription

With a valid prescription, you can fill at any licensed pharmacy. Options:

• Brand-name (Ozempic, Wegovy, Mounjaro, Zepbound): Any major retail pharmacy — CVS, Walgreens, Walmart, etc. Without insurance, expect $900–$1,349/month. With insurance coverage, significant variation by plan.
• Compounded semaglutide or tirzepatide: FDA-registered 503B outsourcing facilities. Same active ingredient, substantially lower cost: $149–$250/month for semaglutide. Your provider can write specifically for a compounding pharmacy if that's your preference.

Curapath doesn't bundle the medication — the prescription goes to whatever pharmacy you choose. See our GLP-1 cost comparison guide for a full breakdown of what each option actually costs in 2026.

Step 5: Start Your Titration

Standard semaglutide titration protocol:

• Weeks 1–4: 0.25mg/week (starting dose — tolerance building)
• Weeks 5–8: 0.5mg/week (first titration)
• Weeks 9–12: 1mg/week (maintenance dose for many patients)
• Weeks 13+: Up to 2mg/week if indicated and tolerated

The titration schedule exists to minimize nausea, which is the most common side effect during dose escalation. Patients who skip titration and start at higher doses have significantly higher rates of GI side effects — the protocol is there for a reason. Follow it.

Who Qualifies for a GLP-1 Telehealth Consultation?

The FDA-approved indication for GLP-1 weight-loss medications applies to adults with:

• BMI ≥ 30 (obesity classification), or
• BMI ≥ 27 with at least one weight-related condition: type 2 diabetes, hypertension, high cholesterol (hyperlipidemia), or obstructive sleep apnea

If you meet this threshold, you're in the qualifying range. The provider will then check for contraindications:

• Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN2)
• History of pancreatitis
• Current pregnancy or breastfeeding
• Severe gastroparesis or other GI motility disorders

None of these disqualify you absolutely from telehealth — but most do prevent GLP-1 prescribing regardless of channel. If you have a relevant history, the provider will discuss alternatives.

Being on other medications is not a disqualifier. Insulin, metformin, blood pressure medications — these require dose coordination, not avoidance. The provider will flag interactions and adjust accordingly.

Telehealth vs. In-Person: What's the Same and What's Different

The one thing telehealth genuinely cannot replicate is a physical examination — auscultation, palpation, blood pressure measurement with clinic-grade equipment. For a typical GLP-1 consultation, none of these are clinically required. If your case involves unusual complexity — an undiagnosed cardiac condition, an active thyroid concern, unexplained weight changes beyond the scope of obesity — a telehealth provider will tell you to seek in-person evaluation. That's not a gap in telehealth; it's appropriate clinical judgment.

How Curapath Works

Curapath is a telehealth intake platform built specifically for GLP-1 and weight management consultations. Here's how we're different from the large telehealth platforms (Hims, Ro, Noom Med):

• No subscription. $49 covers the consultation. That's it. No ongoing membership, no required medication bundle, no lock-in.
• Prescription to any pharmacy. When a provider approves your prescription, it goes wherever you choose — your local pharmacy, a mail-order service, a 503B compounding pharmacy for lower-cost semaglutide. We don't take a margin on your medication.
• Focused specialty. Curapath providers specialize in GLP-1 weight management, men's health, and women's health consultations. These aren't general practitioners asked to handle weight management between other appointments — it's their focus.
• 24-hour turnaround. Provider review is typically complete within 24 hours of intake submission. No scheduling. No waiting for an opening in a provider's calendar.

What Happens If You're Not Approved?

If the provider determines you're not currently a candidate — BMI below threshold, active contraindication, medication interaction — you'll receive a clear explanation. The $49 consultation covers this outcome too; you've paid for a clinical evaluation, not a guaranteed prescription.

Common reasons for non-approval and what to do:

• BMI below 27: GLP-1 medications aren't indicated. Consider discussing weight management approaches with your primary care provider.
• Thyroid history (MTC/MEN2): Hard contraindication. No telehealth platform will override this — nor should they.
• Pancreatitis history: Providers may decline or request more detailed records before proceeding. In-person evaluation may be recommended.
• Insulin-dependent diabetes with complex management: Coordinating GLP-1 with active insulin regimens can be complex. Some cases are better managed in-person with an endocrinologist involved.

Frequently Asked Questions

How long does a GLP-1 telehealth consultation take?

The intake form takes 10–15 minutes to complete. Provider review is typically done within 24 hours. Total time from starting your intake to receiving a prescription: usually less than 24 hours for straightforward cases. Compare that to in-person care, which typically involves booking weeks out, driving to the clinic, and waiting 3–6 weeks for prior authorization if insurance is involved.

Do I need to be on camera for a telehealth GLP-1 consultation?

For asynchronous platforms like Curapath, no. You submit your intake in writing — the provider reviews your health history and responds with a decision. No live video required. Some telehealth platforms do require synchronous video visits; Curapath uses an asynchronous intake model that doesn't require scheduling a specific time slot.

What if I've tried semaglutide before and it didn't work?

Prior GLP-1 experience is relevant information for the provider. Factors that affect outcomes include starting dose, titration speed, medication source, and whether the dosing reached therapeutic levels. The provider will review your history and may recommend a different approach — different dose schedule, switch to tirzepatide, or adjunct behavioral support. A prior unsuccessful experience doesn't automatically disqualify you.

Is the prescription I receive from a telehealth provider valid everywhere?

Yes. A prescription issued by a state-licensed telehealth provider is legally equivalent to one written in a clinic. Pharmacies — retail, mail-order, and compounding — accept telehealth prescriptions without distinction. The prescription includes the same required information: provider credentials, DEA number if applicable, medication, dose, and quantity.

How do I know if compounded semaglutide is right for me?

Cost is usually the deciding factor. Compounded semaglutide from a registered 503B pharmacy runs $149–$250/month — versus $936–$1,349/month for brand-name Wegovy or Ozempic without insurance. The active ingredient is the same. If you have insurance that covers brand-name GLP-1s, the calculus may differ. Your provider can write for either option; the choice is yours. See our GLP-1 cost comparison guide for a full breakdown.

Can I use my FSA or HSA for a Curapath consultation?

Yes. Telehealth consultations with licensed providers qualify as eligible medical expenses under most FSA and HSA plans. Curapath can provide an itemized receipt after your consultation for reimbursement. GLP-1 medications (whether brand-name or compounded) also qualify as FSA/HSA-eligible expenses when prescribed by a licensed provider.

What states does Curapath operate in?

Curapath providers are licensed across most U.S. states. Coverage varies by provider licensing — when you complete your intake, you'll specify your state of residence and we'll match you with a licensed provider in your state. If we don't currently have coverage in your state, we'll let you know during intake before you're charged.

What's the difference between Curapath and a GLP-1 subscription service?

Subscription services (Hims, Ro, Noom Med) bundle consultation and medication into a monthly fee — typically $199–$399/month. You're locked into their compounding pharmacy at their price. Curapath charges $49 for the consultation and writes your prescription to whatever pharmacy you choose. If you source compounded semaglutide for $150–$200/month independently, your total cost is lower. If you prefer a single bill and don't want to manage pharmacy relationships, a bundled service is simpler. The tradeoff is flexibility vs. convenience.

Related reading: Ozempic vs Mounjaro: Which GLP-1 Is Right for You? — compare semaglutide vs tirzepatide results, side effects, and cost side-by-side. · GLP-1 Medications: Complete Cost Comparison Guide (2026) — brand-name vs compounded pricing, telehealth platform comparison, and how to get a cheap GLP-1 prescription online without insurance. · GLP-1 Side Effects & Safety Guide — what to expect on semaglutide and tirzepatide, how titration reduces side effects, and when to contact your provider.

Have questions about whether GLP-1 telehealth is right for you? Start your intake and our provider team will evaluate your specific situation. See also our GLP-1 cost comparison guide or our full range of telehealth services including men's health and women's health consultations.